The Effects of 6-gingerol on Proliferation, Differentiation, and Maturation of Osteoblast-like MG-63 Cells

Overview

Journal Braz J Med Biol Res

Specialties Biology
General Medicine

Date 2015 Apr 30

PMID 25923459

Citations 15

Authors

J Z Fan

X Yang

Z G Bi

Affiliations

Soon will be listed here.

Abstract

We investigated whether 6-gingerol affects the maturation and proliferation of osteoblast-like MG63 cells in vitro. Osteoblast-like MG63 cells were treated with 6-gingerol under control conditions, and experimental inflammation was induced by tumor necrosis factor-α (TNF-α). Expression of different osteogenic markers and cytokines was analyzed by real-time PCR, Western blotting, and enzyme-linked immunosorbent assay. In addition, alkaline phosphatase (ALP) enzyme activity and biomineralization as markers for differentiation were measured. Treatment with 6-gingerol resulted in insignificant effects on the proliferation rate. 6-Gingerol induced the differentiation of osteoblast-like cells with increased transcription levels of osteogenic markers, upregulated ALP enzyme activity, and enhanced mineralized nodule formation. Stimulation with TNF-α led to enhanced interleukin-6 and nuclear factor-κB expression and downregulated markers of osteoblastic differentiation. 6-Gingerol reduced the degree of inflammation in TNF-α-treated MG-63 cells. In conclusion, 6-gingerol stimulated osteoblast differentiation in normal physiological and inflammatory settings, and therefore, 6-gingerol represents a promising agent for treating osteoporosis or bone inflammation.

Citing Articles

Ginger extract loaded Fe2O3/MgO-doped hydroxyapatite: Evaluation of biological properties for bone-tissue engineering.

Bhattacharjee A, Bose S J Am Ceram Soc. 2024; 107(4):2081-2092.

PMID: 38855017 PMC: 11160932. DOI: 10.1111/jace.19568.

Effectiveness of Calcium Hydroxide and Gingerols Mixture as a Novel Obturation Material for Infected Root in Primary Teeth: A Randomized Clinical Trial.

Qasem F, Awad S, Elagamy R Int J Dent. 2024; 2024:5528260.

PMID: 38362239 PMC: 10869195. DOI: 10.1155/2024/5528260.

Molecular mechanism of a novel root-end filling material containing zirconium oxide on the osteogenic/odontogenic differentiation of human osteosarcoma MG-63 cells.

Chen Y, Huang Y, Lu X Front Bioeng Biotechnol. 2023; 11:1269246.

PMID: 37901837 PMC: 10613028. DOI: 10.3389/fbioe.2023.1269246.

Immunomodulatory and anti-inflammatory therapeutic potential of gingerols and their nanoformulations.

Yucel C, Seker Karatoprak G, Acikara O, Akkol E, Barak T, Sobarzo-Sanchez E Front Pharmacol. 2022; 13:902551.

PMID: 36133811 PMC: 9483099. DOI: 10.3389/fphar.2022.902551.

Anti-Osteoporosis Effect of Leaf Hexane Fraction through Regulating Osteoclast and Osteoblast Differentiation.

Phromnoi K, Yodkeeree S, Pintha K, Mapoung S, Suttajit M, Saenjum C Molecules. 2022; 27(3).

PMID: 35164085 PMC: 8840259. DOI: 10.3390/molecules27030824.

References

Seck T, Diel I, Bismar H, Ziegler R, Pfeilschifter J . Expression of Interleukin-6 (IL-6) and IL-6 receptor mRNA in human bone samples from pre- and postmenopausal women. Bone. 2002; 30(1):217-22. DOI: 10.1016/s8756-3282(01)00652-4. View

Mashhadi N, Ghiasvand R, Askari G, Hariri M, Darvishi L, Mofid M . Anti-oxidative and anti-inflammatory effects of ginger in health and physical activity: review of current evidence. Int J Prev Med. 2013; 4(Suppl 1):S36-42. PMC: 3665023. View

Niempoog S, Pawa K, Amatyakul C . The efficacy of powdered ginger in osteoarthritis of the knee. J Med Assoc Thai. 2013; 95 Suppl 1:S59-64. View

Bhutani G, Gupta M . Emerging therapies for the treatment of osteoporosis. J Midlife Health. 2014; 4(3):147-52. PMC: 3952405. DOI: 10.4103/0976-7800.118991. View

Ebetino F, Hogan A, Sun S, Tsoumpra M, Duan X, Triffitt J . The relationship between the chemistry and biological activity of the bisphosphonates. Bone. 2011; 49(1):20-33. DOI: 10.1016/j.bone.2011.03.774. View

Roggia C, Tamone C, Cenci S, Pacifici R, Isaia G . Role of TNF-alpha producing T-cells in bone loss induced by estrogen deficiency. Minerva Med. 2004; 95(2):125-32. View

Chen H, Soroka D, Haider J, Ferri-Lagneau K, Leung T, Sang S . [10]-Gingerdiols as the major metabolites of [10]-gingerol in zebrafish embryos and in humans and their hematopoietic effects in zebrafish embryos. J Agric Food Chem. 2013; 61(22):5353-60. PMC: 3840088. DOI: 10.1021/jf401501s. View

Lane N, Kelman A . A review of anabolic therapies for osteoporosis. Arthritis Res Ther. 2003; 5(5):214-22. PMC: 193734. DOI: 10.1186/ar797. View

Kassem M . Cellular and molecular effects of growth hormone and estrogen on human bone cells. APMIS Suppl. 1997; 71:1-30. View

10.

Daudt L, Cavagni J, Gaio E, Souza A, Torres I, Ferreira M . Effect of inhaled corticosteroid on TNF-α production and alveolar bone loss in Wistar rats. Arch Oral Biol. 2011; 56(11):1398-403. DOI: 10.1016/j.archoralbio.2011.04.018. View

11.

Curate F . Osteoporosis and paleopathology: a review. J Anthropol Sci. 2014; 92:119-46. DOI: 10.4436/JASS.92003. View

12.

Dugasani S, Pichika M, Nadarajah V, Balijepalli M, Tandra S, Korlakunta J . Comparative antioxidant and anti-inflammatory effects of [6]-gingerol, [8]-gingerol, [10]-gingerol and [6]-shogaol. J Ethnopharmacol. 2009; 127(2):515-20. DOI: 10.1016/j.jep.2009.10.004. View

13.

Paramdeep G . Efficacy and tolerability of ginger (Zingiber officinale) in patients of osteoarthritis of knee. Indian J Physiol Pharmacol. 2014; 57(2):177-83. View

14.

Dunstan C, Felsenberg D, Seibel M . Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease. Nat Clin Pract Oncol. 2006; 4(1):42-55. DOI: 10.1038/ncponc0688. View

15.

Nanes M . Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene. 2003; 321:1-15. DOI: 10.1016/s0378-1119(03)00841-2. View

16.

Gilbert L, He X, Farmer P, Rubin J, Drissi H, van Wijnen A . Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem. 2001; 277(4):2695-701. DOI: 10.1074/jbc.M106339200. View

17.

Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y . Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci U S A. 1993; 90(24):11924-8. PMC: 48097. DOI: 10.1073/pnas.90.24.11924. View

18.

Kalajzic I, Staal A, Yang W, Wu Y, Johnson S, Feyen J . Expression profile of osteoblast lineage at defined stages of differentiation. J Biol Chem. 2005; 280(26):24618-26. DOI: 10.1074/jbc.M413834200. View

19.

Bellido T, Stahl N, Farruggella T, Borba V, Yancopoulos G, Manolagas S . Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. J Clin Invest. 1996; 97(2):431-7. PMC: 507034. DOI: 10.1172/JCI118432. View

20.

Kurihara N, Bertolini D, Suda T, Akiyama Y, Roodman G . IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol. 1990; 144(11):4226-30. View